Gross Pathology - Shrinking Brain Blues

- Generalized cortical atrophy: The brain shrinks, leading to:
- Widened sulci: The grooves on the brain's surface become broader.
- Narrowed gyri: The folds of the brain become thinner.
- Hydrocephalus ex vacuo: Compensatory enlargement of ventricles as brain parenchyma is lost. CSF pressure remains normal.
- Hippocampal atrophy: Severe shrinkage of the hippocampus is a key feature.
⭐ Hippocampal atrophy is a key early finding on MRI, correlating with the severity of memory loss.
Extracellular Pathology - Plaque Attack
- Senile (neuritic) plaques are extracellular aggregates of Amyloid-β (Aβ) peptides, primarily the toxic Aβ42 fragment, formed by enzymatic cleavage of Amyloid Precursor Protein (APP).
- Staining: Visualized with Congo Red (apple-green birefringence) and Thioflavin-S.
- Cerebral Amyloid Angiopathy (CAA): Aβ deposition in vessel walls, increasing hemorrhage risk.
⭐ Aβ42's hydrophobic nature makes it highly prone to aggregation, initiating plaque formation.

Intracellular Pathology - Tangled Tau
- Normal Function: Tau protein is an intracellular microtubule-associated protein (MAP) that provides structural stability to neuronal axons, acting like railway ties for axonal transport.
- Pathology: In Alzheimer's disease, Tau becomes pathologically hyperphosphorylated.
- This causes Tau to detach from microtubules, leading to their destabilization and disintegration.
- The abnormal Tau protein misfolds and aggregates into insoluble Paired Helical Filaments (PHFs).
- Result - NFTs: These PHFs accumulate within the neuron to form Neurofibrillary Tangles (NFTs).
- Appearance: NFTs have a classic intracytoplasmic, "flame-shaped" appearance in pyramidal neurons.
- Staining: Visualized with silver stains (Bielschowsky, Gallyas) and immunohistochemistry for Tau.

⭐ High-Yield: Tangle density and distribution (measured by Braak staging) correlate much more strongly with the severity of cognitive decline in Alzheimer's disease than amyloid plaque load.
Genetic Factors - The Gene Scene
| Onset Type | Key Genes & Loci | Notes |
|---|---|---|
| Late-Onset (>95%) | ApoE4 allele on Chr 19 | ↑ Risk for sporadic AD |
| (Sporadic) | ApoE2 allele on Chr 19 | ↓ Protective |
| Early-Onset (<5%) | APP on Chr 21 | Amyloid Precursor Protein |
| (Familial) | PSEN1 on Chr 14 | Presenilin 1 (most common) |
| PSEN2 on Chr 1 | Presenilin 2 |
⭐ The ApoE4 allele is the strongest genetic risk factor for late-onset AD.
High‑Yield Points - ⚡ Biggest Takeaways
- Core pathology involves extracellular Aβ-amyloid plaques (derived from APP) and intracellular neurofibrillary tangles of hyperphosphorylated tau.
- Gross anatomy shows diffuse cortical atrophy, most prominent in the hippocampus and temporoparietal lobes.
- Cerebral amyloid angiopathy (CAA) is a frequent co-pathology, elevating the risk of lobar hemorrhage.
- ApoE4 allele is the most significant genetic risk factor for late-onset AD.
- Early-onset familial AD is linked to mutations in APP, PSEN1, and PSEN2.
Continue reading on Oncourse
Sign up for free to access the full lesson, plus unlimited questions, flashcards, AI-powered notes, and more.
CONTINUE READING — FREEor get the app